Femasys Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Femasys Inc. (FEMY) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$7.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$3.88M, a 1153.15% decline year-over-year.
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $368.45K.
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$3.88M.
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$2.80M.
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $5.81M.
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$18.26M, a 308.64% decline from fiscal 2023.
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $8.75M.
- Femasys Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$11.82M, a 155.08% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.82M 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$3.88M 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $5.81M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $1.12M 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$233.69K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $368.45K 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | -$18.26M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$14.10M 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$8.19M 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | -$3.88M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $8.75M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$4.27M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$2.26M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$2.80M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$11.82M 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$8.78M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$5.67M 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$3.02M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $21.46M 10-K/A · filed 2023-07-24 | |||
| 2021-09-30 | $23.96M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $26.54M 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | -$1.31M 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | -$3.09M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | -$1.85M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$964.91K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |